Drug Shortage Report for MYLAN-GALANTAMINE ER
| Report ID | 209416 |
| Drug Identification Number | 02339439 |
| Brand name | MYLAN-GALANTAMINE ER |
| Common or Proper name | GALANTAMINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30BT, 100BT |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-12-11 |
| Actual start date | 2023-12-18 |
| Estimated end date | 2024-03-19 |
| Actual end date | 2024-03-19 |
| Shortage status | Resolved |
| Updated date | 2024-03-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2024-03-25 | French | Compare |
| v17 | 2024-03-25 | English | Compare |
| v16 | 2024-03-06 | French | Compare |
| v15 | 2024-03-06 | English | Compare |
| v14 | 2024-02-28 | French | Compare |
| v13 | 2024-02-28 | English | Compare |
| v12 | 2024-01-30 | French | Compare |
| v11 | 2024-01-30 | English | Compare |
| v10 | 2024-01-10 | French | Compare |
| v9 | 2024-01-10 | English | Compare |
| v8 | 2023-12-19 | French | Compare |
| v7 | 2023-12-19 | English | Compare |
| v6 | 2023-12-13 | French | Compare |
| v5 | 2023-12-13 | English | Compare |
| v4 | 2023-12-13 | French | Compare |
| v3 | 2023-12-13 | English | Compare |
| v2 | 2023-11-06 | French | Compare |
| v1 | 2023-11-06 | English | Compare |
Showing 1 to 18 of 18